Concepedia

Deanna L. Kelly

DL

146

Publications

6.9K

Citations

46

H-Index

1998

Active since

Affiliations

University of Maryland, Baltimore(Current)

National Institute on Drug Abuse

University of Maryland, College Park

Johns Hopkins University

National Institutes of Health

Deanna L. Kelly is an author at University of Maryland, Baltimore specializing in medicine, psychiatry, and schizophrenia.

ORCID

Top concepts

Publications per year

1998–2023

146

Publications

146

Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders

Maria Fiorentino, Anna Sapone, Stefania Senger et al. · Molecular Autism · 2016 · 456 citations · Full text

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

José de León, Georgios Schoretsanitis, Robert L. Smith et al. · Pharmacopsychiatry · 2021 · 234 citations · Full text

Adjunctive Treatment With a Dopamine Partial Agonist, Aripiprazole, for Antipsychotic-Induced Hyperprolactinemia: A Placebo-Controlled Trial

Joo-Cheol Shim, Jae-Goo K Shin, Deanna L. Kelly et al. · American Journal of Psychiatry · 2007 · 210 citations

Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles

Jacqueline I. Goldstein, L. Fredrik Jarskog, Chris Hilliard et al. · Nature Communications · 2014 · 177 citations · Full text

Prevalence of Celiac Disease and Gluten Sensitivity in the United States Clinical Antipsychotic Trials of Intervention Effectiveness Study Population

Nicola G. Cascella, D. Kryszak, Bushra Bhatti et al. · Schizophrenia Bulletin · 2009 · 166 citations · Full text

Rows per page

1–5 of 146